about
Eliminating barriers to personalized medicine: learning from neurofibromatosis type 1Comparative approaches to the study of physiology: Drosophila as a physiological tool.Pheochromocytoma: implications in tumorigenesis and the actual managementRisk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage studyIntracranial malignant triton tumor in a patient with neurofibromatosis type 1: case report and review of the literature.Neurofibromatosis type 1 is not associated with subarachnoid haemorrhage.Small bowel volvulus as a complication of von Recklinghausen's disease: a case report.Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population.Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.Perioperative management of neurofibromatosis type 1.Neurofibromatosis type 1 and pregnancy: The transformation of a nodular to cystic neurofibroma in the cervical region.Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.Pediatric neurofibromatosis 1 and parental stress: a multicenter studyNonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.Ophthalmological assessment of children with neurofibromatosis type 1.Barriers of the peripheral nerve.Tumor-suppressor Genes, Cell Cycle Regulatory Checkpoints, and the SkinCharacterization of early communicative behavior in mouse models of neurofibromatosis type 1.LEOPARD Syndrome: Clinical Features and Gene Mutations.Neurofibromatosis type 1 associated with papillary thyroid carcinoma incidentally detected by thyroid ultrasonography: a case report.Dysregulated gene expressions of MEX3D, FOS and BCL2 in human induced-neuronal (iN) cells from NF1 patients: a pilot study.Patterns of Novel Alleles and Genotype/Phenotype Correlations Resulting from the Analysis of 108 Previously Undetected Mutations in Patients Affected by Neurofibromatosis Type I.Neurofibromatosis: types 1 and 2.A controlled register-based study of 460 neurofibromatosis 1 patients: increased fracture risk in children and adults over 41 years of age.Neurofibromatosis 1-related osteopenia often progresses to osteoporosis in 12 years.Fast and robust next-generation sequencing technique using ion torrent personal genome machine for the screening of neurofibromatosis type 1 (NF1) gene.The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.Congenital anomalies in neurofibromatosis 1: a retrospective register-based total population study.Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.The pregnancy in neurofibromatosis 1: A retrospective register-based total population study.[Eye involvement in neurofibromatosis].
P2860
Q26828988-AB79D2C3-A227-41DD-9EBC-155AE2E3AC77Q27015827-6ED510EA-31CF-4905-B60D-339C6FB25D1CQ27024128-DA31E18B-F134-42CC-A1EB-0494A3CE3B2CQ30444375-C724372B-6DFD-4296-A46B-8E73F5B53D29Q30620656-51DEC799-731F-48EF-8B89-842EDA619B8CQ33757823-F5F79D1F-7AB5-4E61-A57B-F568D2B79E0FQ33801446-96420918-60C5-4E12-9D57-BCA88ACD0AB4Q35635417-29EEEC16-5716-41FA-836E-79F33D7EE9A9Q36008044-D88EDB31-041C-4B8C-AB59-AB8113E8A4ABQ36071038-195D3D74-C7AE-4BE4-B342-F5936FECC0FDQ36196424-53CE8DCD-B12A-4CB3-84D5-2FE6F86B655CQ36425828-EC96CE0C-2FD4-452E-9350-ED38F6825F0BQ37524978-BFE7FBB1-87DB-4616-BD57-8A0735F991E5Q38084894-73F8C9DD-C8F1-4ADE-B90D-CBFD32043728Q38109483-5F32F234-E162-4250-BBF7-00A4537BF71DQ38199106-850C2A8D-3ED8-4461-AC19-A1098E5F2047Q38537584-FAF5F59A-37ED-435B-84D1-EB8E0EC6A5B0Q38607455-5AA2A293-28A4-4552-A344-F680993431F4Q41880278-4C8286D0-DD9E-4630-80FE-0592121D1CF5Q42321145-9ED1A47A-293F-4834-B0B7-EAEF69D49326Q42639726-25695FA4-A3AA-4DE2-9D69-2663BA5A21E7Q43171487-EF3C7719-72D1-46ED-B550-763E2BB5F7C9Q43463241-40A0F70D-6E9F-4C58-9CFA-057E8726FBD1Q45187619-02E9D087-87C7-4143-AD3F-1FD5DFFC1C11Q45846222-0CCE038A-92C9-4F91-98F5-F75E4577E668Q47176817-9BCFE0A7-4504-47F3-8AEE-82293A28CE14Q48219696-3F1F5E47-E34D-4B3E-BD17-AE7EA2B6440FQ50044115-14522E7A-9DBE-4BE5-8893-23D9E20FEB19Q52718681-F81FD5C1-B919-4111-80F8-FD30C1626DCEQ53495202-5CFF1198-0600-41E5-98A6-334530C6277CQ53924359-1631BA21-E431-4672-9134-A56BA5C9B6A5
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The pathoetiology of neurofibromatosis 1
@ast
The pathoetiology of neurofibromatosis 1
@en
The pathoetiology of neurofibromatosis 1
@nl
type
label
The pathoetiology of neurofibromatosis 1
@ast
The pathoetiology of neurofibromatosis 1
@en
The pathoetiology of neurofibromatosis 1
@nl
prefLabel
The pathoetiology of neurofibromatosis 1
@ast
The pathoetiology of neurofibromatosis 1
@en
The pathoetiology of neurofibromatosis 1
@nl
P2093
P2860
P1476
The pathoetiology of neurofibromatosis 1
@en
P2093
Anthony M Heape
Eeva-Mari Jouhilahti
Juha Peltonen
Sirkku Peltonen
P2860
P304
P356
10.1016/J.AJPATH.2010.12.056
P407
P577
2011-03-31T00:00:00Z